Zimmer Biomet Holdings, Inc.

46
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US98956P1021
USD
99.49
-1.5 (-1.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Zimmer Biomet Holdings, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
830.00
1,036.00
1,067.00
403.00
499.00
-274.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-104.00
-455.00
-396.00
-311.00
-134.00
-427.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,697.00
1,499.00
1,581.00
1,284.00
1,499.00
1,204.00
Cash Flow from Investing Activities
-1,975.00
-888.00
-778.00
-529.00
-503.00
-613.00
Cash Flow from Financing Activities
326.00
-484.00
-763.00
-843.00
-1,306.00
-421.00
Net Cash Inflow / Outflow
66.00
109.00
40.00
-102.00
-323.00
184.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
19.00
-17.00
0.00
-14.00
-13.00
15.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Zimmer Biomet Holdings, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
830.8
1048.909
-218.00
-20.79%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-104.8
-65.329
-39.00
-60.42%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1697.1
955.772
742.00
77.56%
Cash Flow from Investing Activities
-1975.7
-193.874
-1,782.00
-919.06%
Cash Flow from Financing Activities
326
-755.173
1,081.00
143.17%
Net Cash Inflow / Outflow
66.4
7.526
59.00
782.27%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
19
0.801
19.00
2272.03%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 13.19% vs -5.20% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
1,697.10
1,499.40
13.19%